Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mass Behavior | 1 | 2021 | 68 | 0.91 | Why? |
| Dermatomycoses | 1 | 2018 | 55 | 0.69 | Why? |
| Surgical Wound Infection | 3 | 2018 | 501 | 0.61 | Why? |
| Burn Units | 1 | 2018 | 179 | 0.60 | Why? |
| Crowding | 1 | 2021 | 731 | 0.57 | Why? |
| Fungi | 1 | 2018 | 471 | 0.55 | Why? |
| Cyclonic Storms | 1 | 2018 | 236 | 0.55 | Why? |
| Coronavirus OC43, Human | 1 | 2021 | 1157 | 0.51 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.47 | Why? |
| Burns | 1 | 2018 | 466 | 0.44 | Why? |
| Cesarean Section | 2 | 2018 | 2089 | 0.38 | Why? |
| Health Facilities | 2 | 2016 | 1230 | 0.35 | Why? |
| Occupational Exposure | 3 | 2021 | 4742 | 0.34 | Why? |
| Respiratory Tract Infections | 4 | 2014 | 6817 | 0.34 | Why? |
| Infectious Disease Incubation Period | 3 | 2013 | 1033 | 0.32 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 2 | 2018 | 711 | 0.31 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.29 | Why? |
| Cross Infection | 5 | 2016 | 8675 | 0.29 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.27 | Why? |
| Staphylococcal Infections | 2 | 2018 | 1099 | 0.25 | Why? |
| Civil Defense | 2 | 2017 | 1687 | 0.25 | Why? |
| Decision Support Techniques | 1 | 2010 | 903 | 0.24 | Why? |
| Epidemiological Monitoring | 1 | 2015 | 3493 | 0.24 | Why? |
| International Cooperation | 1 | 2015 | 3436 | 0.23 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.20 | Why? |
| Disease Outbreaks | 5 | 2018 | 27595 | 0.20 | Why? |
| Carrier State | 1 | 2011 | 2100 | 0.19 | Why? |
| Information Dissemination | 1 | 2015 | 2986 | 0.19 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 9706 | 0.19 | Why? |
| Health Personnel | 5 | 2021 | 29646 | 0.18 | Why? |
| Vital Signs | 1 | 2020 | 257 | 0.18 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.17 | Why? |
| Penicillium | 1 | 2017 | 14 | 0.17 | Why? |
| Community-Acquired Infections | 1 | 2010 | 2328 | 0.17 | Why? |
| Baltimore | 1 | 2018 | 220 | 0.17 | Why? |
| Gloves, Surgical | 1 | 2017 | 50 | 0.16 | Why? |
| Air Movements | 1 | 2017 | 68 | 0.16 | Why? |
| Viruses | 1 | 2010 | 2238 | 0.16 | Why? |
| Arabia | 1 | 2015 | 36 | 0.16 | Why? |
| Infection Control | 4 | 2020 | 23131 | 0.15 | Why? |
| Syndrome | 1 | 2020 | 1310 | 0.14 | Why? |
| Antibiotic Prophylaxis | 2 | 2018 | 399 | 0.14 | Why? |
| Vagina | 1 | 2017 | 327 | 0.14 | Why? |
| Mycophenolic Acid | 1 | 2016 | 383 | 0.13 | Why? |
| Obstetrics | 2 | 2020 | 859 | 0.13 | Why? |
| Middle East | 2 | 2016 | 1418 | 0.13 | Why? |
| Mandatory Programs | 1 | 2018 | 291 | 0.13 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.12 | Why? |
| Virus Diseases | 1 | 2010 | 3779 | 0.12 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.12 | Why? |
| Humans | 31 | 2021 | 930598 | 0.10 | Why? |
| Public Health Surveillance | 2 | 2021 | 3129 | 0.10 | Why? |
| Mycoses | 1 | 2017 | 589 | 0.10 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.10 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.09 | Why? |
| Influenza, Human | 3 | 2018 | 10779 | 0.08 | Why? |
| Interviews as Topic | 1 | 2015 | 1952 | 0.08 | Why? |
| Probability | 1 | 2010 | 923 | 0.08 | Why? |
| Operating Rooms | 1 | 2017 | 1841 | 0.08 | Why? |
| Child | 4 | 2021 | 70012 | 0.07 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Coronavirus | 3 | 2021 | 18339 | 0.07 | Why? |
| Nose | 1 | 2011 | 1093 | 0.07 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.07 | Why? |
| Organizational Policy | 1 | 2010 | 694 | 0.07 | Why? |
| Intensive Care Units, Pediatric | 1 | 2011 | 1098 | 0.07 | Why? |
| Outpatients | 1 | 2017 | 3417 | 0.07 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.06 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.06 | Why? |
| Republic of Korea | 1 | 2015 | 5858 | 0.06 | Why? |
| Herpesviridae Infections | 1 | 2004 | 172 | 0.06 | Why? |
| Bronchoscopes | 1 | 2004 | 168 | 0.06 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.05 | Why? |
| Sterilization | 1 | 2004 | 294 | 0.05 | Why? |
| Communicable Disease Control | 1 | 2010 | 29620 | 0.05 | Why? |
| Wound Closure Techniques | 1 | 2018 | 18 | 0.05 | Why? |
| Masks | 2 | 2018 | 8528 | 0.05 | Why? |
| Tetracycline | 1 | 2018 | 33 | 0.05 | Why? |
| Academic Medical Centers | 1 | 2011 | 3088 | 0.05 | Why? |
| Software | 1 | 2010 | 2501 | 0.05 | Why? |
| Animal Husbandry | 1 | 2018 | 162 | 0.04 | Why? |
| Female | 11 | 2020 | 380317 | 0.04 | Why? |
| Opportunistic Infections | 1 | 2004 | 602 | 0.04 | Why? |
| Air Microbiology | 2 | 2018 | 1322 | 0.04 | Why? |
| Immunosuppressive Agents | 1 | 2016 | 6331 | 0.04 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.04 | Why? |
| Observation | 1 | 2017 | 80 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Korea | 1 | 2016 | 89 | 0.04 | Why? |
| Disease Transmission, Infectious | 3 | 2016 | 9044 | 0.04 | Why? |
| Travel | 1 | 2015 | 7220 | 0.04 | Why? |
| North Carolina | 1 | 2018 | 571 | 0.04 | Why? |
| Absenteeism | 1 | 2018 | 287 | 0.04 | Why? |
| Male | 8 | 2020 | 367725 | 0.04 | Why? |
| Bronchoscopy | 1 | 2004 | 991 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Adult | 6 | 2020 | 244371 | 0.04 | Why? |
| Protective Clothing | 1 | 2018 | 468 | 0.04 | Why? |
| Water Microbiology | 1 | 2017 | 248 | 0.03 | Why? |
| Wound Healing | 1 | 2018 | 424 | 0.03 | Why? |
| Efficiency, Organizational | 1 | 2018 | 482 | 0.03 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2016 | 8843 | 0.03 | Why? |
| Saudi Arabia | 2 | 2016 | 4423 | 0.03 | Why? |
| Incidence | 1 | 2015 | 25622 | 0.03 | Why? |
| Intensive Care Units | 2 | 2018 | 29594 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
| Length of Stay | 1 | 2010 | 11042 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| North America | 1 | 2017 | 1400 | 0.03 | Why? |
| Global Health | 1 | 2015 | 13911 | 0.03 | Why? |
| Standard of Care | 1 | 2018 | 1297 | 0.03 | Why? |
| Infant | 2 | 2011 | 30274 | 0.03 | Why? |
| Anti-Bacterial Agents | 1 | 2013 | 10083 | 0.03 | Why? |
| Adolescent | 3 | 2018 | 86841 | 0.03 | Why? |
| Prospective Studies | 1 | 2015 | 43301 | 0.03 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2004 | 2426 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2016 | 1329 | 0.02 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Gynecology | 1 | 2017 | 741 | 0.02 | Why? |
| Retrospective Studies | 2 | 2018 | 105322 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.02 | Why? |
| Family Characteristics | 1 | 2018 | 2551 | 0.02 | Why? |
| Critical Illness | 1 | 2011 | 17281 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2004 | 5150 | 0.02 | Why? |
| Canada | 1 | 2020 | 6018 | 0.02 | Why? |
| Time Factors | 1 | 2010 | 31397 | 0.02 | Why? |
| Pregnancy | 2 | 2020 | 23879 | 0.02 | Why? |
| Young Adult | 2 | 2015 | 93724 | 0.02 | Why? |
| Respiratory Protective Devices | 1 | 2018 | 1637 | 0.02 | Why? |
| Influenza A virus | 1 | 2018 | 2234 | 0.02 | Why? |
| Ambulatory Care Facilities | 1 | 2017 | 2063 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Immunization Programs | 1 | 2018 | 2006 | 0.02 | Why? |
| Base Sequence | 1 | 2013 | 3581 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2016 | 5440 | 0.02 | Why? |
| Health Resources | 1 | 2018 | 2592 | 0.02 | Why? |
| Particulate Matter | 1 | 2017 | 3249 | 0.02 | Why? |
| Acyclovir | 1 | 2004 | 154 | 0.02 | Why? |
| Guideline Adherence | 1 | 2016 | 2309 | 0.02 | Why? |
| Practice Guidelines as Topic | 3 | 2020 | 15421 | 0.02 | Why? |
| DNA, Viral | 1 | 2013 | 2521 | 0.02 | Why? |
| Herpesvirus 3, Human | 1 | 2004 | 228 | 0.01 | Why? |
| United States | 2 | 2020 | 46150 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Logistic Models | 1 | 2016 | 9089 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2016 | 6740 | 0.01 | Why? |
| Middle Aged | 5 | 2018 | 270681 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Immune Sera | 1 | 2004 | 884 | 0.01 | Why? |
| Secondary Prevention | 1 | 2004 | 762 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2016 | 8248 | 0.01 | Why? |
| Health Policy | 1 | 2018 | 6242 | 0.01 | Why? |
| Educational Status | 1 | 2004 | 1451 | 0.01 | Why? |
| Surgical Procedures, Operative | 1 | 2013 | 2662 | 0.01 | Why? |
| Renal Dialysis | 1 | 2013 | 4358 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Equipment Contamination | 1 | 2004 | 1308 | 0.01 | Why? |
| Phylogeny | 1 | 2013 | 13341 | 0.01 | Why? |
| Data Collection | 1 | 2004 | 1769 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2013 | 4927 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Aged | 3 | 2016 | 215776 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2013 | 88759 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Disinfection | 1 | 2004 | 2912 | 0.01 | Why? |
| Treatment Outcome | 1 | 2016 | 51732 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Immunization, Passive | 1 | 2004 | 10067 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2016 | 48226 | 0.01 | Why? |
| Lung | 1 | 2016 | 31049 | 0.01 | Why? |
| Neoplasms | 1 | 2004 | 17251 | 0.00 | Why? |
| Antiviral Agents | 1 | 2004 | 41703 | 0.00 | Why? |
Perl's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(66)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_